The Rajasthan government has taken decisive measures by permanently revoking the drug licences of 31 medical stores after an investigation identified significant irregularities in claims made under the Rajasthan Government Health Scheme (RGHS). This action is part of the state’s broader initiative aimed at enhancing transparency and accountability within the health insurance programme.

The Rajasthan State Health Assurance Agency conducted a thorough investigation, discovering that multiple medical stores allegedly conspired with doctors and beneficiaries to submit fraudulent claims. In several instances, fake signatures of doctors were reportedly employed, and claims were filed for items not covered by the scheme, rather than genuine medicinal products.

According to Gayatri Rathore, the Principal Secretary of Medical and Health, the stringent action taken was a direct consequence of the findings from the investigation. Alongside the cancellation of licences, further steps include the recovery of excess payments, temporary suspension of TMS services at various outlets, and the de-paneling of errant stores.

Geographical Distribution of Cancelled Licences

Among the medical stores whose licences were cancelled, 11 are located in Jaipur, nine in Bharatpur, and two each in Nagaur and Dholpur. Additionally, one licence has been revoked in each of the districts of Hanumangarh, Bhilwara, Sikar, Jodhpur, and Alwar. This widespread action highlights the government’s commitment to addressing corruption and malpractice within its health services.

To bolster efforts against such malpractices, the state has implemented an AI-based monitoring system designed to scrutinise the medicine claims submitted under RGHS. This advanced technology aims to automatically identify issues such as inflated prices, incorrect product mapping, and instances of fraudulent claims.

Recent audits facilitated by this new system uncovered excessive pricing in claims for medications like Exemptia 40 mg, Denberi injection, Terifrac (Teriparatide), and Trulicity 1.5 mg. Alarmingly, many medical stores claimed prices that were significantly higher than market value and frequently neglected to provide the required minimum discount set by RGHS.

Further Actions and Future Plans

Harjeelal Atal, CEO of Rajasthan State Health Assurance Agency, reported that TMS services for ten medical stores have been temporarily suspended as part of the ongoing enforcement actions. Meanwhile, 13 additional stores have received show-cause notices for their alleged infractions. These measures reflect the state’s stringent approach to regulating the medical supply chain.

In light of these findings and actions, government officials are in the process of formulating a new action plan aimed at further mitigating profiteering and financial misconduct in medicine claims made under the RGHS. The emphasis will likely be on enhancing the enforcement of existing regulations and leveraging technology to identify and address irregular activities promptly.

The Rajasthan government’s initiatives come in response to increasing public concern regarding the integrity of health services and the protection of beneficiaries’ rights. By implementing these robust measures, officials hope to restore faith in the healthcare system and ensure fairness in medical claims handling.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share